Alerts will be sent to your verified email
Verify Email
PHRMASI
|
Phaarmasia
|
Norris Medicines
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-4.64 % | 47.03 % | -8.9 % |
|
5yr average Equity Multiplier
|
2.31 | -2.46 | 1.02 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 0.6 | 0.0 |
|
5yr Avg Net Profit Margin
|
-2.3 % | -30.66 % | 0.0 |
|
Price to Book
|
2.06 | 0.0 | 11.85 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-185.24 Days | 97.28 Days | 0.0 |
|
Inventory Days
|
80.36 Days | 165.43 Days | 0.0 |
|
Days Receivable
|
92.79 Days | 69.98 Days | 0.0 |
|
Days Payable
|
365.75 Days | 260.51 Days | 68.55 Days |
|
5yr Average Interest Coverage Ratio
|
-67.17 | -1.37 | 0.0 |
|
5yr Avg ROCE
|
-3.88 % | -19.87 % | -8.89 % |
|
5yr Avg Operating Profit Margin
|
-3.07 % | -6.94 % | 0.0 |
|
5 yr average Debt to Equity
|
0.0 | -3.0 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | -15.97 % | -28.89 % |
|
5yr Average Return on Assets
|
-2.07 % | -18.92 % | -8.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.51 % | 34.0 % | 42.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.04 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Phaarmasia
|
Norris Medicines
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|